News
U.S. Food and Drug Administration officials should encourage the thoughtful and careful evaluation of drugs.
4don MSN
Confusion at NIH as administration halts, then releases, billions of dollars for scientific research
Billions of dollars of NIH research were stuck in limbo for hours after OMB directed the agency to halt further funding and ...
Eisai and Biogen's Alzheimer's drug Leqembi continued to slow progress of the disease with no new safety issues four years ...
Eli Lilly said on Thursday that its newer diabetes drug Mounjaro outperformed Trulicity, its previously top-selling ...
1d
Tasting Table on MSN10 Modern Food Safety Rules No One Followed In The '70s
In the 1970s, many food handlers didn't have the knowledge we do now. Examine with us some of the modern rules that were ...
The FDA's top regulator of cancer drugs played a key role in the rejection of a skin cancer therapy from Replimune Group, ...
7h
Pharmaceutical Technology on MSNManufacturing issues at Novo facility disrupt Regeneron drug review
R egeneron has received an US Food and Drug Administration (FDA) rejection for a new blood cancer therapy and expects ...
The FDA's top regulator of cancer drugs interceded in a review of a Replimune skin cancer therapy, contributing to its ...
Skittles, Nestlé and Hershey pledge to remove artificial colors, but experts argue these changes are merely cosmetic, urging ...
Despite this, one in five young adults who meet the criteria for the drugs are uninsured and one-third denied having a routine place for healthcare.
10d
Futurism on MSNThe FDA Is Using an AI to "Speed Up" Drug Approvals and Insiders Say It's Making Horrible Mistakes
Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...
FDA Commissioner Marty Makary said the FDA’s review process will not slow down despite layoffs at the Department of Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results